Free Biopharma Daily Stock Updates - 04/08/21

$XBI $132.57 +1%

Want to access our searchable database of over 900 catalyst events and more? Try BiopharmIQ for 30 days free, no credit card required. Check it out here!

Covid Updates


$IBRX -1% Preliminary Phase 1b data reported. source


$MRNA +2% Publication of antibody persistence data out to 6 months following the second dose. source


Pipeline Updates


$ATOS -5% Expanded access treatment underway. source


$PRVB -41% FDA noted additional data would be required for BLA. source


$APRE +15% Eprenetapopt granted Orphan Drug Designation. source


$AUPH +2% Additional data from pivotal trial presented at SCM21. source


$RNLX +5% Presented data at SCM21. source


$GILD -1% FDA approval to Trodelvy®. source


Finance Updates


$KMPH -1% Amendment to the definitive collaboration and license agreement with GPC. source


$GLPG +1% Amendment to the share subscription agreement closed in 2019 with $GILD. source


$JAGX +3% Update to equity purchase agreement. source


$DRNA +3% Sold royalty rights for OXLUMO to $RPRX. source

0 comments